ES2120992T3 - Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos. - Google Patents

Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos.

Info

Publication number
ES2120992T3
ES2120992T3 ES92305130T ES92305130T ES2120992T3 ES 2120992 T3 ES2120992 T3 ES 2120992T3 ES 92305130 T ES92305130 T ES 92305130T ES 92305130 T ES92305130 T ES 92305130T ES 2120992 T3 ES2120992 T3 ES 2120992T3
Authority
ES
Spain
Prior art keywords
antibiotics
carbapenemo
derivatives
methyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92305130T
Other languages
English (en)
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuhiko Watanabe
Eiji Nakayama
Hiroshi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2120992T3 publication Critical patent/ES2120992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE LA FORMULA (I): EN LA CUAL: R1 ES HIDROGENO O UN GRUPO ALQUIL SUSTUTIDO O INSUSTITUIDO; Y A REPRESENTA UN NUMERO DE GRUPOS CICLICOS O ACICLICOS CON CONTENIDO DE NITROGENO. LOS COMPUESTOS SON VALIDOS COMO ANTIBIOTICOS QUE SON RESISTENTES A LA DEHIDROPEPTIDASA I IN VIVO. TAMBIEN SE PRESENTAN METODOS PARA PREPARAR LOS COMPUESTOS Y EL USO DE LOS MISMOS.
ES92305130T 1991-06-04 1992-06-04 Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos. Expired - Lifetime ES2120992T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13154591 1991-06-04
JP34573791 1991-12-27
JP3052192 1992-02-18
JP9128392 1992-04-10

Publications (1)

Publication Number Publication Date
ES2120992T3 true ES2120992T3 (es) 1998-11-16

Family

ID=27459269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92305130T Expired - Lifetime ES2120992T3 (es) 1991-06-04 1992-06-04 Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos.

Country Status (20)

Country Link
EP (1) EP0518558B1 (es)
JP (1) JP2559949B2 (es)
KR (1) KR100247855B1 (es)
CN (1) CN1030767C (es)
AT (1) ATE170521T1 (es)
AU (1) AU651887B2 (es)
CA (1) CA2070305A1 (es)
CZ (1) CZ167792A3 (es)
DE (1) DE69226815T2 (es)
DK (1) DK0518558T3 (es)
ES (1) ES2120992T3 (es)
FI (1) FI101226B1 (es)
HU (2) HU218289B (es)
IE (1) IE921796A1 (es)
IL (1) IL102093A (es)
MX (1) MX9202670A (es)
NO (1) NO302475B1 (es)
NZ (1) NZ243022A (es)
RU (1) RU2093514C1 (es)
TW (1) TW203612B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
HU218676B (hu) * 1992-03-11 2000-10-28 Sankyo Co. Ltd. Antimikrobiális karbapenemszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
EP0581502B1 (en) * 1992-07-21 1998-10-21 Zeneca Limited Antibiotic carbapenem compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
JP3848693B2 (ja) * 1994-07-06 2006-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規カルバペネム誘導体
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
KR100386993B1 (ko) * 1995-12-21 2003-12-18 상꾜 가부시키가이샤 1-메틸카르바페넴유도체
NZ332453A (en) * 1996-04-26 2000-09-29 Sankyo Co (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections
JP2001500118A (ja) 1996-08-17 2001-01-09 ゼネカ・リミテッド ファルネシルタンパク質トランスフェラーゼ阻害剤としての3―メルカプトピロリジン
WO2000034282A1 (en) * 1998-12-07 2000-06-15 Sankyo Company, Limited 1-methylcarbapenem derivatives
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
WO2003024928A2 (en) 2001-09-14 2003-03-27 Novo Nordisk A/S Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
EP3430013B1 (en) 2016-03-16 2023-11-15 Orchid Pharma Limited Carbapenem compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
NZ237191A (en) * 1990-02-23 1992-12-23 Sankyo Co 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
TW198034B (es) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
HU218676B (hu) * 1992-03-11 2000-10-28 Sankyo Co. Ltd. Antimikrobiális karbapenemszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására

Also Published As

Publication number Publication date
CN1030767C (zh) 1996-01-24
HU218289B (en) 2000-07-28
FI101226B (fi) 1998-05-15
IE921796A1 (en) 1992-12-16
DE69226815D1 (de) 1998-10-08
FI922561L (fi) 1992-12-05
HU211822A9 (en) 1995-12-28
HK1011980A1 (en) 1999-07-23
CZ167792A3 (en) 1995-12-13
CN1069494A (zh) 1993-03-03
KR930000515A (ko) 1993-01-15
AU651887B2 (en) 1994-08-04
EP0518558B1 (en) 1998-09-02
NO922185D0 (no) 1992-06-03
JP2559949B2 (ja) 1996-12-04
EP0518558A1 (en) 1992-12-16
JPH05339269A (ja) 1993-12-21
AU1739092A (en) 1993-03-11
FI922561A0 (fi) 1992-06-03
NO302475B1 (no) 1998-03-09
ATE170521T1 (de) 1998-09-15
MX9202670A (es) 1993-01-01
DK0518558T3 (da) 1999-05-31
NZ243022A (en) 1993-07-27
FI101226B1 (fi) 1998-05-15
IL102093A (en) 1996-12-05
DE69226815T2 (de) 1999-05-20
HU9201871D0 (en) 1992-08-28
IL102093A0 (en) 1993-01-14
NO922185L (no) 1992-12-07
HUT61551A (en) 1993-01-28
CA2070305A1 (en) 1992-12-05
KR100247855B1 (ko) 2000-05-01
TW203612B (es) 1993-04-11
RU2093514C1 (ru) 1997-10-20

Similar Documents

Publication Publication Date Title
ES2120992T3 (es) Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos.
PT87261A (pt) Processo de preparacao de heparinas de baixo peso molecular,com estrutura regular e de composicoes farmaceuticas que as contem
ES2112377T3 (es) Procedimiento para la preparacion de derivados del taxano y productos intermedios.
ES2063219T3 (es) Aminoacidos ciclicos exentos de lactama.
PT99402A (pt) Processo para a preparacao de derivados de imino ciclicos e de composicoes farmaceuticas que os contem
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
ES2090855T3 (es) Derivados de naftaleno, procedimientos para su preparacion y productos intermediarios apropiados.
ES2154674T3 (es) Derivados de 1,5-benzodiacepinas con actividad antagonista o agonista de cck.
ES2077010T3 (es) Eteres de celulosa no ionicos solubles en agua y su uso en pinturas.
ES2001923A6 (es) Procedimiento para preparar 3-amino-dihidro-(1)-benzo(tio)piranos.
ES8700262A1 (es) Un compuesto
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
IE44868L (en) Improving flammability retardancy
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
NO155391C (no) Polyesteramider og deres anvendelse ved klebing av organiske eller uorganiske substrater og som stoepemasse samt blandinger inneholdende polyesteramidene.
ES2161470T3 (es) Resinas de melamina modificadas y su utilizacion para la produccion de estratificados aptos para su conformacion posterior.
AR245688A1 (es) Compuestos trigliceridos de amonio cuaternario, su preparacion y su uso.
ES2037699T3 (es) Compuestos coloreados solubles en agua, procedimiento para su preparacion, y su utilizacion como colorantes.
ES2044876T3 (es) Compuestos de reaccion por adicion, procedimiento para su produccion y su utilizacion.
ES2171704T3 (es) Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.
ES2174323T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2055089T3 (es) Procedimiento para preparar 4-metilpirazoles.
PT90719A (pt) Processo de preparacao de 2-etenil-3,4,5,6-tetra-hidrotieno{4,3,2-ef}{3} benzazepinas substituidas e de composicoes farmaceuticas que as contem
GB1340674A (en) Urethanes toys or amusement devices suitable for use as stilts

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 518558

Country of ref document: ES